What is the minimum age for administering the Quantiferon Gold (Interferon-Gamma Release Assay) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Minimum Age for QuantiFERON Gold Testing

The minimum recommended age for QuantiFERON Gold (QFT) testing is 5 years, as children under 5 years of age have higher rates of indeterminate results and potentially lower test sensitivity. 1

Age-Related Considerations

Children Under 5 Years

  • Higher caution is warranted when using IGRAs (including QFT) in children under 5 years due to:
    • Limited performance data in this age group 1
    • Higher rates of progression from latent TB infection to active disease 1
    • Higher risk of severe forms of TB disease (meningitis, disseminated disease) 1
    • Age-related immunologic differences affecting test performance 1
    • Higher proportion of indeterminate results 1, 2
    • Practical challenges in collecting sufficient blood volume 1

Children 5 Years and Older

  • Less caution is required when implementing QFT testing in children ≥5 years 1
  • Older children are:
    • Less likely to develop active TB or severe forms of disease 1
    • More similar to adults in immune response 1
    • Logistically easier to test (ability to draw sufficient blood) 1

Performance Characteristics by Age

Under 2 Years

  • Suboptimal sensitivity (84.6%) in microbiologically confirmed TB cases 3
  • Higher rates of indeterminate results 2
  • Lower interferon-gamma production in response to mitogen control 4, 2
  • Increasing age is associated with lower rates of indeterminate results (OR 0.948 per month of age) 2

2-4 Years

  • Better performance than <2 years but still with limitations
  • Sensitivity of 95.0% in microbiologically confirmed TB cases 3
  • Still higher risk of discordant TST+/QFT- results compared to older children 3

5 Years and Older

  • Performance similar to adults 1, 3
  • Sensitivity of 89.1% in microbiologically confirmed TB cases 3
  • Lower rates of indeterminate results 1

Technical Considerations

  • Blood must be incubated with test antigens within 12 hours of collection 1, 5
  • Lymphocyte viability must be maintained 1
  • 5-mL blood sample is required, which may be difficult to obtain from young children 1
  • Environmental factors like temperature and season may affect test performance 2

Clinical Implications

  • For children <5 years, especially <2 years:

    • Consider using both TST and QFT when there is strong clinical suspicion or high-risk TB contact 3
    • Be aware of higher rates of indeterminate results and potential false negatives 1, 2
  • For children ≥5 years:

    • QFT can be used with greater confidence, similar to adults 1
    • May be used as a single test in low-risk screening scenarios 3

Pitfalls and Caveats

  • Never rely solely on QFT results to exclude TB disease, especially in symptomatic patients 5
  • Interpret results in conjunction with clinical, radiographic, and microbiological findings 5
  • Be aware that immunocompromised patients have higher risk of false-negative results 5
  • Young age and elevated inflammatory markers (ESR) are associated with lower positive control responses 2
  • Tobacco smoke exposure may negatively affect test performance 2

While the test can technically be performed in children of any age, the evidence strongly supports using 5 years as the minimum recommended age for routine QFT testing due to more reliable performance and fewer technical challenges.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.